Media
EASTGATE BIOTECH ANNOUNCES THAT IT HAS RECEIVED A SUBSTANTIAL ORDER FOR GLUCORA, ITS NATURAL GLUCOSE MANAGEMENT PRODUCT
May 2, 2016
We are pleased that we have received our first material order for Glucora” says Anna Gluskin, EastGate Biotech’s CEO. “We believe that Glucora is a product with mass market appeal and will play a key role in the company’s diabetes franchise.
Read moreEastgate Biotech CEO Anna Gluskin talks to ‘TheStockRadio.com’ about their products and delivery technology
February 8, 2016
We look forward to introducing the benefits of such delivery, that is now available through our nutraceutical products currently being sold on the market, to a larger audience” continues Gluskin.
Read moreEastGate Patent for Lorazopem
January 19, 2016
EASTGATE BIOTECH RECEIVES NOTICE OF PUBLICATION FROM THE US PATENT AND TRADEMARK OFFICE FOR TWO PATENTS FOR THE COMPANY’S PROPRIETARY INTRAORAL LORAZEPAM SPRAY
Read moreDo You Really Need An Antibiotic?
January 13, 2016
Shortly before I completed this column, I talked to a paraplegic patient who must use a catheter regularly to empty her bladder. This resulted in repeated infections in spite of five different antibiotics! She reported that use of UTI E-Drops resolved her dilemma.
Read moreuti-e-drops-order-2
January 6, 2016
Preferred Nutrition placed an order for E-drops which is the company’s natural and herbal alternative that assists to rid the body of UTI infections painlessly and effectively without side effects of synthetic drugs.
Read moreEASTGATE BIOTECH ANNOUNCES THE COMMENCEMENT OF SCALE-UP MANUFACTURING ACTIVITIES FOR ITS PROPRIETARY INTRAORAL INSULIN TABLET
September 29, 2015
To date, the company is successfully advancing in a formulation development of a 25 IU intraoral insulin tablet, designed to manage mealtime glucose levels.
Read moreEASTGATE BIOTECH CREATES AN ONLINE DIRECTORY AS A MARKETING TOOL FOR ITS NUTRACEUTICAL PRODUCT
September 24, 2015
EASTGATE BIOTECH CREATES AN ONLINE DIRECTORY AS A MARKETING TOOL FOR ITS NUTRACEUTICAL PRODUCT
Read moreUNIVERSITY OF GUELPH AND EASTGATE BIOTECH
July 7, 2015
Previously the company announced that its research collaboration with the University of Guelph involved measuring the antimicrobial activity of the company's natural antibacterial products, Cleanezze™ and Vclean™
Read moreEASTGATE BIOTECH ANNOUNCES THAT IMPEX HEALTHCARE WILL DISTRIBUTE ONE OF ITS PRODUCTS GLUCORA
June 16, 2015
EastGate Biotech Corp. (OTC PINK: ETBI), an emerging pharmaceutical company has announced that Impex Healthcare (www.ImpexHealthcare.com) will commence the distribution and marketing of one of the company’s natural products, Glucora, in Bangladesh along with future distribution of other glucose management products.
Read moreEASTGATE BIOTECH ANNOUNCES COLLABORATION WITH THE UNIVERSITY OF GUELPH, DEPARTMENT OF MOLECULAR AND CELLULAR BIOLOGY, FOR ITS NATURAL ANTIBACTERIAL PRODUCTS
May 28, 2015
EastGate Biotech Corp. (OTCBB: ETBI), has announced today its collaboration with the University of Guelph, Canada, Department of Molecular and Cellular Biology. The collaboration involves evaluation of the antimicrobial activity of the company’s natural antibacterial products, Cleanezze™ and VClean™.
Read more